Table 1.
Descriptive data, by year, region, age and sex, for HAdV infections by species and genotype (n = 105)
| |
HAdV-B |
HAdV-C |
HAdV-E |
TOTAL |
|||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |
HAdV-3 |
HAdV-7 |
HAdV-11 |
Total |
HAdV-1 |
HAdV-2 |
HAdV-5 |
HAdV-6 |
Total |
HAdV-4 |
Total |
|
|||||||||||
| n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | ||
|
Year |
|
|
|
|
|||||||||||||||||||
| 2003 |
0 |
0% |
0 |
0% |
0 |
0% |
0 |
0% |
1 |
50% |
0 |
0% |
0 |
0% |
1 |
50% |
2 |
100% |
0 |
0% |
0 |
0% |
2 |
| 2004 |
0 |
0% |
0 |
0% |
0 |
0% |
0 |
0% |
0 |
0% |
0 |
0% |
0 |
0% |
0 |
0% |
0 |
0% |
0 |
0% |
0 |
0% |
0 |
| 2005 |
2 |
40% |
0 |
0% |
2 |
40% |
4 |
80% |
0 |
0% |
0 |
0% |
1 |
20% |
0 |
0% |
1 |
20% |
0 |
0% |
0 |
0% |
5 |
| 2006 |
3 |
38% |
0 |
0% |
0 |
0% |
3 |
38% |
2 |
25% |
2 |
25% |
1 |
13% |
0 |
0% |
5 |
63% |
0 |
0% |
0 |
0% |
8 |
| 2007 |
2 |
20% |
0 |
0% |
1 |
10% |
3 |
30% |
3 |
30% |
1 |
10% |
3 |
30% |
0 |
0% |
7 |
70% |
0 |
0% |
0 |
0% |
10 |
| 2008 |
3 |
30% |
4 |
40% |
1 |
10% |
8 |
80% |
0 |
0% |
2 |
20% |
0 |
0% |
0 |
0% |
2 |
20% |
0 |
0% |
0 |
0% |
10 |
| 2009 |
9 |
29% |
5 |
16% |
1 |
3% |
15 |
48% |
6 |
19% |
5 |
16%c |
4 |
13% |
0 |
0% |
15 |
48% |
1 |
3% |
1 |
3% |
31 |
| 2010 |
3 |
8% |
5 |
13% |
3 |
8% |
11 |
28% |
10 |
26% |
10 |
26% |
6 |
15% |
2 |
5% |
28 |
28 |
0 |
0% |
0 |
0% |
39 |
|
Region |
|
|
|
|
|||||||||||||||||||
| Alexandria |
8 |
33% |
0 |
0% |
0 |
0% |
8 |
33% |
7 |
29% |
5 |
21% |
2 |
8% |
1 |
4% |
15 |
63% |
1 |
4% |
1 |
4% |
24 |
| Delta |
2 |
22% |
3 |
33% |
1 |
11% |
6 |
67%c |
3 |
33% |
0 |
0% |
0 |
0% |
0 |
0% |
3 |
33% |
0 |
0% |
0 |
0% |
9 |
| Greater Cairo |
8 |
19% |
8 |
19% |
7 |
17% |
23 |
55% |
5 |
12% |
6 |
14% |
7 |
17% |
1 |
2% |
19 |
45% |
0 |
0% |
0 |
0% |
42 |
| Upper Egypt |
4 |
13% |
3 |
10% |
0 |
0% |
7 |
23% |
7 |
23% |
9 |
30% |
6 |
20% |
1 |
3% |
23 |
77% |
0 |
0% |
0 |
0% |
30 |
|
Age |
|
|
|
|
|||||||||||||||||||
| < 2 years |
3 |
8% |
5 |
14% |
0 |
0% |
8 |
22% |
8 |
22% |
8 |
22% |
10 |
28% |
1 |
3% |
27 |
75% |
1 |
3% |
1 |
3% |
36 |
| 2-17 years |
11 |
23% |
9 |
19% |
7 |
15% |
27 |
56% |
7 |
15% |
9 |
19% |
3 |
6% |
2 |
4% |
21 |
44% |
0 |
0% |
0 |
0% |
48 |
| ≥ 18 years |
7 |
37% |
0 |
0% |
1 |
5% |
8 |
42% |
6 |
32% |
3 |
16% |
2 |
11% |
0 |
0% |
11 |
58% |
0 |
0% |
0% |
0% |
19 |
| Unknown |
1 |
50% |
0 |
0% |
0 |
0% |
1 |
50% |
1 |
50% |
0 |
0% |
0 |
0% |
0 |
0% |
1 |
50% |
0 |
0% |
0 |
0% |
2 |
|
Sex |
|
|
|
|
|||||||||||||||||||
| Male |
7 |
17% |
8 |
19% |
4 |
10% |
19 |
45% |
7 |
17% |
9 |
21% |
5 |
12% |
2 |
5% |
23 |
55% |
0 |
0% |
0 |
0% |
42 |
| Female |
14 |
23% |
6 |
10% |
4 |
7% |
24 |
39% |
14 |
23% |
11 |
18% |
10 |
16% |
1 |
2% |
36 |
59% |
1 |
2% |
1 |
2% |
61 |
| Unknown |
1 |
50% |
0 |
0% |
0 |
0% |
1 |
50% |
1 |
50% |
0 |
0% |
0 |
0% |
0 |
0% |
1 |
50% |
0 |
0% |
0 |
0% |
2 |
| TOTAL | 22 | 21% | 14 | 13% | 8 | 8% | 44 | 42% | 22 | 21% | 20 | 19% | 15 | 14% | 3 | 3% | 60 | 57% | 1 | 1% | 1 | 1% | 105 |